Your session is about to expire
← Back to Search
Endovascular Graft
Endovascular Graft for Abdominal Aortic Aneurysm (FENP Trial)
N/A
Waitlist Available
Led By James F. McKinsey, MD
Research Sponsored by Cook Research Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is studying the safety and effectiveness of two types of endovascular grafts for the treatment of abdominal aortic aneurysms.
Eligible Conditions
- Abdominal Aortic Aneurysm
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Procedural Success
Technical Success
Treatment Success
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: EndovascularExperimental Treatment1 Intervention
Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft
2008
N/A
~30
Find a Location
Who is running the clinical trial?
Cook Research IncorporatedLead Sponsor
30 Previous Clinical Trials
253,839 Total Patients Enrolled
James F. McKinsey, MDPrincipal InvestigatorMount Sinai-West
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are not expected to live for more than 2 years.You have a large abdominal aortic aneurysm, which is a bulge in the main blood vessel in your abdomen.You have an abdominal aortic aneurysm that has been growing by more than half a centimeter in the past 6 months.You have a large, deep ulcer in a specific part of your aorta.
Research Study Groups:
This trial has the following groups:- Group 1: Endovascular
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.